Psychological and Psychosocial Interventions for Schizophrenia with Substance Use Disorders
This systematic review examines schizophrenia dual diagnosis treatment focusing on psychological and psychosocial interventions. It addresses a critical gap for patients with co-occurring substance use disorders. The research highlights the challenges…
Effects of Prescribed Medical Cannabis on Driving: Study Protocol Analysis
Australian researchers have developed a medical cannabis driving safety protocol to assess real-world driving performance in patients using prescribed THC. This two-phase trial aims to provide critical evidence on driving safety for medical cannabis…
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review
This systematic review highlights cannabinoids diabetic neuropathy pain relief, showing significant benefits in three of four trials. THC-containing products demonstrated the strongest efficacy for diabetic nerve pain. These findings provide…
The efficacy and safety of cannabinoids for mental and substance use disorders: a systematic review and meta-analysis
A landmark cannabinoids mental health disorders systematic review published in The Lancet Psychiatry examines cannabinoids for mental health and substance use disorders. This comprehensive analysis addresses critical evidence gaps. The findings directly…
Why Averages Fail Palliative Cannabis Patients – A New Framework
Randomized controlled trials often fail to capture what palliative care cannabis patients actually experience. A new contextual effectiveness framework argues that averaging subjective outcomes obscures genuine individual benefit. This Evidence Brief…
Plasma Cannabinoid Pharmacokinetics After Vaporized Cannabis Inhalation
This study investigates cannabinoid pharmacokinetics vaporized cannabis, focusing on how cannabidiol (CBD) influences THC plasma concentrations. It provides critical data on absorption and metabolism after inhalation. Understanding these interactions is…
Endocannabinoid System in Autism Development Research
Maternal cannabis exposure autism risk is linked to behavioral problems and developmental delays in children. Research shows stronger associations in children with autism spectrum disorder symptoms. Understanding these risks is crucial for clinical…
Insights from the CBD Autism Anxiety Clinical Trial Study
This clinical study on cbd autism anxiety trial results reveals measurable improvements in social interaction and anxiety symptoms in autistic children. The trial used a randomized controlled design to assess CBD oil effects. Findings suggest potential…
Endocannabinoid System Research: Clinical Evidence
The rebuttal-based social norms tailored cannabis intervention shows promise in reducing cannabis use among adolescents. This approach targets specific objections with tailored messages, improving engagement. Clinical evidence supports its effectiveness…
Cannabinoid Clinical Trials: Anxiety & Tourette Syndrome
Cannabinoid clinical trials anxiety disorders reveal modest evidence for CBD in reducing acute anxiety symptoms. THC-dominant formulations may increase anxiety and are not recommended. More rigorous trials are needed to establish cannabinoids as…
